April 4, 2017 / 6:11 AM / 2 months ago

BRIEF-Bioporto Q1 EBIT Loss Narrows To DKK 16.4 Mln

May 7 (Reuters) - Bioporto A/S:

* REG-BIOPORTO ANNOUNCES Q1 2020 REPORT

* Q1 REVENUE DKK 4.2 MILLION VERSUS DKK 5.5 MILLION YEAR AGO

* Q1 EBIT LOSS DKK 16.4 MILLION VERSUS LOSS DKK 17.1 MILLION YEAR AGO

* 2020 GUIDANCE MAINTAINED

* TIMELINE FOR FDA APPLICATION FOR NGAL TEST: BIOPORTO PROJECTS THAT COSTS RELATED TO CLINICAL TRIAL AS WELL AS SUBMISSION OF FDA APPLICATION WILL BE POSTPONED TO SECOND HALF OF 2020. Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below